Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-115 Phase 2 Dose–Response Study in POAG or Ocular Hypertension
jRCT2080220982Phase 2
- Sponsor
- Kowa Company, Ltd.
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in open-angle glaucoma (OAG) and ocular hypertension comparing K-115 ophthalmic solution with Placebo ophthalmic solution (2 arms).
02
Drugs
ripasudil
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on jRCT2080220982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220982.